Ignite Creation Date:
2024-05-05 @ 9:35 PM
Last Modification Date:
2024-10-26 @ 10:06 AM
Study NCT ID:
NCT00916409
Status:
COMPLETED
Last Update Posted:
2017-04-10
First Post:
2009-06-05
Brief Title:
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme GBM
Sponsor:
NovoCure Ltd
Organization:
NovoCure Ltd
Organization Data
Organization:
NovoCure Ltd
Class:
INDUSTRY
Study ID:
EF-14
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NovoCure Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None